Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07179809 · ClinicalTrials.gov registry record · NA
Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer
A NA study, sponsored by M.D. Anderson Cancer Center.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07179809: Clinical Trial NA study, sponsored by M.D. Anderson Cancer Center.
NCT07179809 is a NA study that has not yet begun recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07179809, a NA study, has not yet begun recruiting, sponsored by M.D. Anderson Cancer Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The research study is to learn how the ACLP can best support patients with stable HR+/HER2- MBC.
Interventions
- OTHER Demographics/Lifestyle Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-02-28 |
| Est. Completion | 2029-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07179809
The ClinicalTrials.gov registry entry for NCT07179809 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Demographics/Lifestyle Survey is the first listed.
NCT07179809 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07179809 about?
NCT07179809 is a clinical study titled "Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer". The research study is to learn how the ACLP can best support patients with stable HR+/HER2- MBC.
What is the current status of trial NCT07179809?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-02-28. Estimated completion is 2029-10-01.
What interventions are being tested in trial NCT07179809?
The interventions under investigation include: Demographics/Lifestyle Survey (OTHER).
Who is sponsoring clinical trial NCT07179809?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.